PATENT CLAIM ANALYSIS

Application Number: 16502691
Application Type: Utility
Filing Date: 2019-07
Publication Date: 2019-10
Patent Classification: ["530", "356000"]

Abstract:
An intervention for sleep disorders comprises collagen, a gelatin peptide, or the amino acid glycine; L-theanine; lactucopicrin, deoxylactucopicrin, or another lactucopicrin derivative; hyaluronic acid; epigallocatechin gallate; and quinic acid. The intervention helps regulate pro-inflammatory biomarkers that are often associated with insomnia development and progression. These biomarkers include cytokines and enzymes associated with tryptophan degradation. Inhibition of these enzymes and cytokines improves tryptophan availability and sleep quality, and allows individuals to sleep better with fewer side effects. The novel composition promotes high-quality, deep sleep.

Claim (Index 5):
The method of  claim 4 , wherein the composition additionally comprises a nutritive or non-nutritive sweetener, and a flavoring agent; wherein the flavoring agent comprises as least one flavoring component other than extract of tea ( Camellia sinensis ) and other than extract of chicory ( Cichorium intybus ).

Metadata:
- Claim Count in Document: 9.0
- Percentile: 100.0
- Lexical Diversity: 1.52308
- Patent Class: 530.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15625777', '11547451', '16026541', '14124748', '15755349']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6563093325858209
- 35 USC 102 Novelty (BERT): 0.537587937544821
- Combined Prediction Score: 0.644437193081721
- Mean Citation Score: 196.711726
- Max Citation Score: 377.46136
- Similarity Product: 260.413689886632

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test